Seeing Is Believing

Currently out of the existing stock ratings of Michael Higgins, 62 are a BUY (89.86%), 7 are a HOLD (10.14%).
Analyst Michael Higgins, carries an average stock price target met ratio of 37.72% that have a potential upside of 44.74% achieved within 163 days. Previously, Michael Higgins worked at LADENBURG.
Michael Higgins’s has documented 143 price targets and ratings displayed on 23 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on MRNS, Marinus Pharmaceuticals at 14-Aug-2024.
Analyst best performing recommendations are on ARCT (ARCTURUS THERAPEUTICS HOLDINGS).
The best stock recommendation documented was for ARCT (ARCTURUS THERAPEUTICS HOLDINGS) at 1/13/2017. The price target of $7 was fulfilled within 4 days with a profit of $6.3 (47.37%) receiving and performance score of 118.42.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$12
$7 (140.00%)
$12
2 months 7 days ago
(20-Aug-2025)
0/2 (0%)
$9.11 (315.22%)
Buy
$11
$6 (120.00%)
$11
1 years 2 months 13 days ago
(14-Aug-2024)
0/6 (0%)
$6.55 (147.19%)
Buy
$11
$6 (120.00%)
$19
1 years 7 months 23 days ago
(04-Mar-2024)
0/4 (0%)
$6.61 (150.57%)
Buy
1 years 10 months 16 days ago
(11-Dec-2023)
1/1 (100%)
$-45.93 (-79.19%)
189
What Year was the first public recommendation made by Michael Higgins?